Reuters: Hot Stocks: BRIEF-Stemcells up in premarket after spinal cord injury trial data

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Stemcells up in premarket after spinal cord injury trial data Sep 4th 2012, 12:27 NEW YORK, Sept 4 | Tue Sep 4, 2012 8:27am EDT NEW YORK, Sept 4 (Reuters) - StemCells Inc : * Up 17.1 percent to $2.54 in premarket after spinal cord injury trial data

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions